Brunswick has established a strong and growing expertise in pharma, biotech and healthcare. We have long-term working relationships with our clients, who range in size from the largest global pharmaceutical and healthcare companies to much smaller pre-IPO biotechnology entities.

Our team combines PhD level scientific expertise with corporate finance, accounting and communications experience, qualifying us to help translate the excitement and potential around a client's sophisticated science and technology into an easily understood investment proposition. The team is represented in almost every Brunswick office, enabling us to provide a seamless cross-border service through Europe, the U.S., Asia and Africa to private and public companies in corporate reputation, media relations and profile raising, buy and sell side analyst relationships, crisis or litigation issues and transaction or capital raising activities.